New-found fundamentals of bacterial persistence

Trends in Microbiology

Volumn 20, Issue 12, 2012, Pages 577-585

  Kint, Cyrielle I ^a   Verstraeten, Natalie ^a   Fauvart, Maarten ^a   Michiels, Jan ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antibiotic tolerance; Cancer; Chronic infections; Heterogeneity; Noise; Toxin antitoxin modules

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBIOTIC AGENT; ANTITOXIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL; BACTERIAL SURVIVAL; CELL COMMUNICATION; CELL ISOLATION; CELL POPULATION; DNA STRAND BREAKAGE; DNA SYNTHESIS; DRUG TOLERANCE; DRUG TREATMENT FAILURE; ENZYME METABOLISM; ESCHERICHIA COLI; GENE EXPRESSION; INFECTION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PERSISTER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; GENETIC VARIATION; HUMANS; MICROBIAL VIABILITY;

BACTERIA (MICROORGANISMS);

EID: 84869508228     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.08.009     Document Type: Review

References (80)

1. Lewis K. Persister cells. Annu. Rev. Microbiol. 2010, 64:357-372.
2. Bigger J.W. Treatment of staphylococcal infections with penicillin. Lancet 1944, 244:497-500.
3. Keren I., et al. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 2004, 230:13-18.
4. Balaban N.Q., et al. Bacterial persistence as a phenotypic switch. Science 2004, 305:1622-1625.
5. Dörr T., et al. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 2009, 5:e1000760.
6. Vega N.M., et al. Signaling-mediated bacterial persister formation. Nat. Chem. Biol. 2012, 8:431-433.
7. Fauvart M., et al. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 2011, 60:699-709.
8. Balaban N.Q. Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr. Opin. Genet. Dev. 2011, 21:768-775.
9. Allison K.R., et al. Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr. Opin. Microbiol. 2011, 14:593-598.
10. Nathan C. Fresh approaches to anti-infective therapies. Sci. Transl. Med. 2012, 4:140sr2.
11. Keren I., et al. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 2004, 186:8172-8180.
12. Shah D., et al. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 2006, 6:53.
13. Keren I., et al. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2011, 2:e00100-e00111.
14. Zhang Y., et al. Targeting persisters for tuberculosis control. Antimicrob. Agents Chemother. 2012, 56:2223-2230.
15. Gefen O., et al. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6145-6149.
16. Nguyen D., et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334:982-986.
17. 2S: a universal defense against antibiotics in bacteria. Science 2011, 334:986-990.
18. Grant S.S., et al. Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12147-12152.
19. Dwyer D.J., et al. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 2007, 3:91.
20. Kohanski M.A., et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130:797-810.
21. Kohanski M.A., et al. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 2008, 135:679-690.
22. Foti J.J., et al. Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 2012, 336:315-319.
23. Wu Y., et al. Role of oxidative stress in persister tolerance. Antimicrob. Agents Chemother. 2012, 56:4922-4926.
24. Debbia E.A., et al. Antibiotic persistence: the role of spontaneous DNA repair response. Microb. Drug Resist. 2001, 7:335-342.
25. Vogel J., et al. The small RNA IstR inhibits synthesis of an SOS-induced toxic peptide. Curr. Biol. 2004, 14:2271-2276.
26. Dörr T., et al. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010, 8:e1000317.
27. Unoson C., Wagner E.G. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 2008, 70:258-270.
28. Gurnev P.A., et al. Persister-promoting bacterial toxin TisB produces anion-selective pores in planar lipid bilayers. FEBS Lett. 2012, 586:2529-2534.
29. Moyed H.S., Bertrand K.P. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 1983, 155:768-775.
30. Maisonneuve E., et al. Bacterial persistence by RNA endonucleases. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13206-13211.
31. Harrison J.J., et al. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob. Agents Chemother. 2009, 53:2253-2258.
32. Black D.S., et al. Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 1994, 176:4081-4091.
33. Tripathi A., et al. Additional role for the ccd operon of F-plasmid as a transmissible persistence factor. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12497-12502.
34. Kim Y., Wood T.K. Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem. Biophys. Res. Commun. 2010, 391:209-213.
35. De Groote V.N., et al. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 2009, 297:73-79.
36. Yamaguchi Y., et al. Toxin-antitoxin systems in bacteria and archaea. Annu. Rev. Genet. 2011, 45:61-79.
37. Hansen S., et al. Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis. PLoS ONE 2012, 7:e39185.
38. Kussell E., et al. Bacterial persistence: a model of survival in changing environments. Genetics 2005, 169:1807-1814.
39. Gardner A., et al. Is bacterial persistence a social trait?. PLoS ONE 2007, 2:e752.
40. Lewis K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 2007, 5:48-56.
41. Möker N., et al. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J. Bacteriol. 2010, 192:1946-1955.
42. Leung V., Levesque C.M. A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J. Bacteriol. 2012, 194:2265-2274.
43. Han T.H., et al. Environmental factors affecting indole production in Escherichia coli. Res. Microbiol. 2011, 162:108-116.
44. Imlay J.A. Cellular defenses against superoxide and hydrogen peroxide. Annu. Rev. Biochem. 2008, 77:755-776.
45. Kaern M., et al. Stochasticity in gene expression: from theories to phenotypes. Nat. Rev. Genet. 2005, 6:451-464.
46. Chalancon G., et al. Interplay between gene expression noise and regulatory network architecture. Trends Genet. 2012, 28:221-232.
47. Elowitz M.B., et al. Stochastic gene expression in a single cell. Science 2002, 297:1183-1186.
48. Dhar N., McKinney J.D. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 2007, 10:30-38.
49. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc.) 2005, 70:267-274.
50. Veening J.W., et al. Bistability, epigenetics, and bet-hedging in bacteria. Annu. Rev. Microbiol. 2008, 62:193-210.
51. Rotem E., et al. Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12541-12546.
52. Stewart B., Rozen D.E. Genetic variation for antibiotic persistence in Escherichia coli. Evolution 2012, 66:933-939.
53. Allison K.R., et al. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011, 473:216-220.
54. Mulcahy L.R., et al. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 2010, 192:6191-6199.
55. LaFleur M.D., et al. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 2010, 54:39-44.
56. Levin B.R., Rozen D.E. Non-inherited antibiotic resistance. Nat. Rev. Microbiol. 2006, 4:556-562.
57. De Groote V.N., et al. Pseudomonas aeruginosa fosfomycin resistance mechanisms affect non-inherited fluoroquinolone tolerance. J. Med. Microbiol. 2011, 60:329-336.
58. Sharma S.V., et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
59. Dawson C.C., et al. "Persisters": survival at the cellular level. PLoS Pathog. 2011, 7:e1002121.
60. Glickman M.S., Sawyers C.L. Converting cancer therapies into cures: lessons from infectious diseases. Cell 2012, 148:1089-1098.
61. Spencer S.L., et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009, 459:428-432.
62. LaFleur M.D., et al. Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. J. Antimicrob. Chemother. 2011, 66:820-826.
63. Kohanski M.A., et al. How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 2010, 8:423-435.
64. Yamaguchi Y., Inouye M. Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. Nat. Rev. Microbiol. 2011, 9:779-790.
65. Williams J.J., Hergenrother P.J. Artificial activation of toxin-antitoxin systems as an antibacterial strategy. Trends Microbiol. 2012, 20:291-298.
66. Guglielmini J., Van Melderen L. Bacterial toxin-antitoxin systems: translation inhibitors everywhere. Mob. Genet. Elements 2011, 1:283-290.
67. Blower T.R., et al. Identification and classification of bacterial Type III toxin-antitoxin systems encoded in chromosomal and plasmid genomes. Nucleic Acids Res. 2012, 40:6158-6173.
68. Driessens G., et al. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488:527-530.
69. Chen J., et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
70. + stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
71. Lambert G., et al. An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat. Rev. Cancer 2011, 11:375-382.
72. Schumacher M.A., et al. Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 2009, 323:396-401.
73. Korch S.B., Hill T.M. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 2006, 188:3826-3836.
74. Falla T.J., Chopra I. Joint tolerance to β-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob. Agents Chemother. 1998, 42:3282-3284.
75. Prysak M.H., et al. Bacterial toxin YafQ is an endoribonuclease that associates with the ribosome and blocks translation elongation through sequence-specific and frame-dependent mRNA cleavage. Mol. Microbiol. 2009, 71:1071-1087.
76. Pedersen K., et al. The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell 2003, 112:131-140.
77. Zhang Y., et al. MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. Mol. Cell 2003, 12:913-923.
78. Vázquez-Laslop N., et al. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 2006, 188:3494-3497.
79. Kim Y., et al. Escherichia coli toxin/antitoxin pair MqsR/MqsA regulate toxin CspD. Environ. Microbiol. 2010, 12:1105-1121.
80. Kasari V., et al. The Escherichia coli mqsR and ygiT genes encode a new toxin-antitoxin pair. J. Bacteriol. 2010, 192:2908-2919.